Thomas Maeder. Show Affiliations »
Abstract
Mesh: See more » BiotechnologyDrug CostsDrug IndustryEquipment Design/economicsEquipment and SuppliesHumansOrphan Drug Production/economicsOrphan Drug Production/legislation & jurisprudenceRare Diseases/drug therapyResearch Support as TopicUnited StatesUnited States Food and Drug Administration
Year: 2003 PMID: 12701333 DOI: 10.1038/scientificamerican0503-80
Source DB: PubMed Journal: Sci Am ISSN: 0036-8733 Impact factor: 2.142